More patients die every year from lung cancer than prostate, breast and colon cancer combined (more than 150,000 annually in the U.S. alone). The Auris Monarch Platform has helped improve diagnosis and treatment of lung cancer. As a system designed to do what a surgeon’s hand cannot, the robot enables surgeons to gain access to hard-to-reach nodules in the lungs while maintaining constant vision and control, setting patients up for better surgical outcomes.
To provide a safer and more effective treatment option than what was available on the market, Chris Velis worked with Andrew Tofe to develop the Cerapedics i-FACTOR Peptide Enhanced Bone Graft, creating a new category of bone graft technology to enhance bone repair. This technology has shown a better overall success rate in clinical study disc surgery in fusion of bone, shown to cause less pain and improved function of the spine after surgery. The i-FACTOR technology is the only FDA-cleared biologic for use in cervical spine fusion.
Audax is focused on regenerative medicine in the orthopedics space with the goal of restoring healthy, functional bone and soft tissue. The team is designing minimally-invasive orthopedic products that aim to reduce surgery time and improve patient outcomes while overcoming traditional orthopedic complications like inflammation, infection and poor tissue-biomaterial integration.